Making a Meaningful Difference

A royalty-driven organization differentiated by in-house R&D capabilities developing novel medicines for patients with difficult-to-treat diseases

Revolutionary technologies engineering fit-for-purpose biotherapeutics

Our fully integrated R&D engine is powered by our proprietary platforms and driven by our team of world-class researchers who have a proven ability to discover, develop, and collaborate with partners to commercialize our novel agents globally.

Science that’s focused on transforming areas of high unmet medical need

We thrive on scientific challenges and strive to deliver transformational therapies for patients with difficult-to-treat cancers and other serious diseases. Our pipeline of novel multifunctional therapeutics is supported by our clinically validated platforms for development of antibody-drug conjugates and multispecific antibody therapeutics.